{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:09:07Z","timestamp":1791403747051,"version":"4.3.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.jtauto.2022.100180","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T02:25:11Z","timestamp":1672107911000},"page":"100180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Glutamine deamidation does not increase the immunogenicity of C-peptide in people with type 1 diabetes"],"prefix":"10.1016","volume":"6","author":[{"given":"Abby","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpak","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Tresoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Pakusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3497-3559","authenticated-orcid":false,"given":"Stuart I.","family":"Mannering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2022.100180_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cei.12699","article-title":"The case for an autoimmune aetiology of type 1 diabetes","volume":"183","author":"Mannering","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib2","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2337\/db16-0687","article-title":"Type 1 diabetes prevention: a goal dependent on accepting a diagnosis of an asymptomatic disease","volume":"65","author":"Ziegler","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2337\/dbi19-0022","article-title":"T-cell epitopes and neo-epitopes in type 1 diabetes: a comprehensive update and reappraisal","volume":"69","author":"James","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","article-title":"Immunogenetics of type 1 diabetes: a comprehensive review","volume":"64","author":"Noble","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2022.100180_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2337\/diab.36.1.114","article-title":"Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3\/4 heterozygotes","volume":"36","author":"Nepom","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/dc18-2282","article-title":"Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report","volume":"42","author":"Krischer","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtauto.2022.100180_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db14-0858","article-title":"Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes","volume":"64","author":"Pathiraja","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11892-017-0915-y","article-title":"Deciphering the pathogenesis of human type 1 diabetes (T1D) by interrogating T cells from the \"scene of the crime","volume":"17","author":"Kent","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.jtauto.2022.100180_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/db16-1025","article-title":"Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes","volume":"66","author":"Michels","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/imcb.12442","article-title":"Insulin's other life: an autoantigen in type 1 diabetes","volume":"99","author":"Mannering","year":"2021","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jtauto.2022.100180_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diabres.2015.01.016","article-title":"C-peptide: new findings and therapeutic possibilities","volume":"107","author":"Wahren","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jtauto.2022.100180_bib12","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.1073\/pnas.1809208115","article-title":"Proinsulin C-peptide is an autoantigen in people with type 1 diabetes","volume":"115","author":"So","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.jtauto.2022.100180_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587469","article-title":"Optimization of a method to detect autoantigen-specific T-cell responses in type 1 diabetes","volume":"11","author":"Musthaffa","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00125-018-4760-6","article-title":"Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes","volume":"62","author":"Mannering","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtauto.2022.100180_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667989","article-title":"diabetes: etiological insights, biomarkers and therapeutic targets","volume":"12","author":"Rodriguez-Calvo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1084\/jem.20051251","article-title":"The insulin A-chain epitope recognized by human T cells is posttranslationally modified","volume":"202","author":"Mannering","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtauto.2022.100180_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667870","article-title":"Identifying new hybrid insulin peptides (HIPs) in type 1 diabetes","volume":"12","author":"Mannering","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2337\/dbi17-0030","article-title":"Immune recognition of beta-cells: neoepitopes as key players in the loss of tolerance","volume":"67","author":"James","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/73200","article-title":"Vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope","volume":"6","author":"Anderson","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtauto.2022.100180_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.immuni.2007.05.015","article-title":"A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease","volume":"27","author":"Henderson","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2022.100180_bib21","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3389\/fimmu.2020.01374","article-title":"Coeliac disease pathogenesis: the uncertainties of a well-known immune mediated disorder","volume":"11","author":"Dunne","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib22","doi-asserted-by":"crossref","first-page":"41ra51","DOI":"10.1126\/scitranslmed.3001012","article-title":"Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease","volume":"2","author":"Tye-Din","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jtauto.2022.100180_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtauto.2022.100180_bib24","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/db17-1166","article-title":"Modifying enzymes are elicited by ER stress, generating epitopes that are selectively recognized by CD4(+) T cells in patients with type 1 diabetes","volume":"67","author":"Marre","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib25","article-title":"The role of beta cell stress and neo-epitopes in the immunopathology of type 1 diabetes","volume":"11","author":"Piganelli","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jtauto.2022.100180_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2337\/db12-1214","article-title":"Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes","volume":"63","author":"van Lummel","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jtauto.2022.100180_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cei.12775","article-title":"Human islets and dendritic cells generate post-translationally modified islet autoantigens","volume":"185","author":"McLaughlin","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41590-020-0623-7","article-title":"The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides","volume":"21","author":"Wan","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib29","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jtauto.2022.100180_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.2910190505","article-title":"Characterization of EBV-genome negative \"null\" and \"T\" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma","volume":"19","author":"Schneider","year":"1977","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jtauto.2022.100180_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nri1330","article-title":"Jurkat T cells and development of the T-cell receptor signalling paradigm","volume":"4","author":"Abraham","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2022.100180_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jim.2003.09.004","article-title":"A sensitive method for detecting proliferation of rare autoantigen-specific human T cells","volume":"283","author":"Mannering","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jtauto.2022.100180_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1196\/annals.1337.003","article-title":"CD4+ T cell proliferation in response to GAD and proinsulin in healthy, pre-diabetic, and diabetic donors","volume":"1037","author":"Mannering","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jtauto.2022.100180_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005430","article-title":"Comparison of T cell receptor-induced proximal signaling and downstream functions in immortalized and primary T cells","volume":"4","author":"Bartelt","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2022.100180_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jtauto.2022.100180_bib36","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/s41467-021-25404-x","article-title":"T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8","volume":"12","author":"Tran","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2022.100180_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fimmu.2013.00172","article-title":"Re-directing CD4(+) T cell responses with the flanking residues of MHC class II-bound peptides: the core is not enough","volume":"4","author":"Holland","year":"2013","journal-title":"Front. Immunol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909022000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909022000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:33:11Z","timestamp":1762903991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909022000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":37,"alternative-id":["S2589909022000417"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2022.100180","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamine deamidation does not increase the immunogenicity of C-peptide in people with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2022.100180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100180"}}